First Affiliated Hospital Xi'an Jiaotong University

This study tests whether removing blood clots from heart arteries during emergency treatment can improve long-term heart health. About 6,760 adults having a severe heart attack will be randomly assigned to get standard care or standard care plus clot removal. Researchers will tra…

This study tests whether adding thiotepa to the standard chemotherapy (melphalan) before a stem cell transplant can lower the chance of cancer returning in people with multiple myeloma. It includes 204 adults aged 18-70 who did not achieve complete remission before transplant. Pa…

This study tests whether giving a clot-dissolving drug (rhPro-UK) before standard clot removal helps people who had a stroke up to 24 hours earlier. About 820 participants will receive either the drug or a placebo, and researchers will check if they can live independently after 9…

This early-stage study tests a new type of immune cell therapy (bispecific AbTCR-T cells) in 3 adults with B-cell lymphoma that has returned or not responded to at least two prior treatments. The cells are designed to recognize and attack two markers (CD19 and CD22) on cancer cel…

This study aims to see if a new test using the heart's electrical and mechanical signals can accurately diagnose valvular heart disease. Researchers will recruit 1,300 adults with and without heart valve problems to compare the new test against standard echocardiography. The goal…